Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

FEDERICO HINESTROSA

Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease

NPI
1427215557
CMS profile
109771
Location
ORLANDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$42,460.19

163 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $25,348.36 51
ViiV Healthcare Company $9,144.15 50
Merck Sharp & Dohme LLC $5,121.13 28
ABBVIE INC. $2,414.17 7
Janssen Biotech, Inc. $189.92 13
Theratechnologies Inc. $102.09 6
EMD Serono, Inc. $41.52 2
GlaxoSmithKline, LLC. $34.41 2
PFIZER INC. $17.31 1
Hologic Sales and Service, LLC $16.56 1
Insmed, Inc. $16.24 1
Napo Pharmaceuticals Inc $14.33 1

Page 2 of 4; records 51–100 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

FEDERICO HINESTROSA

NPI 1427215557 · CMS profile ID 109771

Allopathic & Osteopathic Physicians / Internal Medicine / Infectious Disease

ORLANDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1427215557?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
FEDERICO HINESTROSA, NPI 1427215557, CMS profile ID 109771. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1427215557?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). FEDERICO HINESTROSA, NPI 1427215557, CMS profile ID 109771. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1427215557?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
FEDERICO HINESTROSA, NPI 1427215557, CMS profile ID 109771, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 163 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1427215557?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

163 matching records · $42,460.19 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 163 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 163.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ViiV Healthcare Company $29.6709/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001241023 CMS
Merck Sharp & Dohme LLC $2,590.0009/13/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048714575 CMS
Gilead Sciences, Inc. $34.6209/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025541001 CMS
Merck Sharp & Dohme LLC $21.5509/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048261107 CMS
Merck Sharp & Dohme LLC $25.0009/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048261381 CMS
Merck Sharp & Dohme LLC $29.9209/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048716371 CMS
ViiV Healthcare Company $27.6109/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001240965 CMS
Gilead Sciences, Inc. $17.5308/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025911085 CMS
Janssen Biotech, Inc. $20.8108/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988139833 CMS
Gilead Sciences, Inc. $28.8708/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025573721 CMS
Gilead Sciences, Inc. $2,080.0008/21/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1035829337 CMS
ViiV Healthcare Company $25.7608/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001241501 CMS
Gilead Sciences, Inc. $116.3508/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025517093 CMS
Merck Sharp & Dohme LLC $19.4708/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048261387 CMS
Janssen Biotech, Inc. $15.0508/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988139881 CMS
ViiV Healthcare Company $0.6608/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001240893 CMS
ViiV Healthcare Company $9.0908/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001241407 CMS
ViiV Healthcare Company $32.2508/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001242129 CMS
Gilead Sciences, Inc. $34.0507/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025542795 CMS
Janssen Biotech, Inc. $16.3607/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988139871 CMS
ABBVIE INC. $34.7707/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997482437 CMS
ViiV Healthcare Company $23.8907/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001240943 CMS
Gilead Sciences, Inc. $33.7707/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025544261 CMS
EMD Serono, Inc. $20.7607/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032501749 CMS
Janssen Biotech, Inc. $15.3207/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988139853 CMS
ViiV Healthcare Company $25.3107/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001241421 CMS
ViiV Healthcare Company $27.8707/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001242141 CMS
Merck Sharp & Dohme LLC $21.6307/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048848167 CMS
Theratechnologies Inc. $17.6606/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022757797 CMS
Gilead Sciences, Inc. $34.1306/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025542507 CMS
EMD Serono, Inc. $20.7606/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032304963 CMS
ViiV Healthcare Company $18.9506/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001241333 CMS
ViiV Healthcare Company $18.6006/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001241557 CMS
GlaxoSmithKline, LLC. $17.1806/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002647325 CMS
Merck Sharp & Dohme LLC $18.3006/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048261389 CMS
ViiV Healthcare Company $16.6206/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001240931 CMS
Gilead Sciences, Inc. $17.8206/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025489029 CMS
Gilead Sciences, Inc. $32.0006/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025489033 CMS
Gilead Sciences, Inc. $18.9106/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025858235 CMS
Gilead Sciences, Inc. $18.8805/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025859323 CMS
Janssen Biotech, Inc. $8.6005/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988139901 CMS
Theratechnologies Inc. $17.7705/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022757801 CMS
ViiV Healthcare Company $18.7605/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001241469 CMS
Gilead Sciences, Inc. $18.1805/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025886375 CMS
ViiV Healthcare Company $25.1805/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001241489 CMS
Insmed, Inc. $16.2405/12/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978820973 CMS
Janssen Biotech, Inc. $14.2605/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988139957 CMS
ViiV Healthcare Company $7,150.0005/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001242081 CMS
Gilead Sciences, Inc. $34.7105/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025540689 CMS
Merck Sharp & Dohme LLC $20.1005/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048714877 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $43,526.75 237
PY2020 $29,624.50 83
PY2021 $38,319.28 114
PY2022 $44,857.99 119
PY2023 $42,460.19 163
PY2024 $26,959.86 149
PY2025 $50,178.69 188

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,513.51 7
PY2025 Principal investigator $196,001.89 18
PY2024 Recipient $6,553.44 7
PY2024 Principal investigator $461,574.97 21
PY2023 Recipient $1,671.05 6
PY2023 Principal investigator $800,115.64 52
PY2022 Principal investigator $717,182.96 31
PY2021 Principal investigator $2,182,223.78 30
PY2020 Principal investigator $388,642.05 156
PY2019 Recipient $340.48 3
PY2019 Principal investigator $51,638.65 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $2,640.49 12/31/2025 Non-covered Recipient Entity
Orlando Immunology Center
A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Adults Living With HIV No dispute reported 06/30/2026 1232933880
Principal investigator 1 GlaxoSmithKline, LLC. $500.00 11/06/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178407
Principal investigator 1 GlaxoSmithKline, LLC. $40,377.00 10/21/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178138
Principal investigator 1 GlaxoSmithKline, LLC. $950.00 09/16/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178121
Principal investigator 1 GlaxoSmithKline, LLC. $950.00 08/14/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178412
Principal investigator 1 GlaxoSmithKline, LLC. $504.90 07/31/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178112
Recipient ViiV Healthcare Company $40.57 07/23/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318511
Recipient ViiV Healthcare Company $16.31 07/23/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318513
Recipient ViiV Healthcare Company $16.31 07/23/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318515
Principal investigator 1 GlaxoSmithKline, LLC. $52,976.00 07/10/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178117
Principal investigator 1 GlaxoSmithKline, LLC. $1,150.00 06/25/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178403
Principal investigator 1 GlaxoSmithKline, LLC. $504.90 06/23/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178143
Recipient ViiV Healthcare Company $637.22 06/17/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318509
Recipient ViiV Healthcare Company $152.48 06/17/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318777
Recipient ViiV Healthcare Company $325.31 06/17/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318779
Recipient ViiV Healthcare Company $325.31 06/17/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318781
Principal investigator 1 GlaxoSmithKline, LLC. $61,506.00 05/02/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192174512
Principal investigator 1 GlaxoSmithKline, LLC. $150.00 03/28/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192174517
Principal investigator 1 GlaxoSmithKline, LLC. $900.00 03/28/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178148
Principal investigator 1 GlaxoSmithKline, LLC. $504.90 03/21/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192174522
Principal investigator 1 GlaxoSmithKline, LLC. $504.90 03/21/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178135
Principal investigator 1 GlaxoSmithKline, LLC. $504.90 03/21/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178398
Principal investigator 1 GlaxoSmithKline, LLC. $504.90 03/21/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178417
Principal investigator 1 ABBVIE INC. $3,100.00 02/13/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER PA
M20-350 - Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE) Pibrentasvir (PIB) No dispute reported 06/30/2026 1202451247
Principal investigator 1 GlaxoSmithKline, LLC. $27,773.00 01/28/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178127